New applications for traditional jobless benefits fell slightly last week to 1.48 million, but they remain stubbornly high three months after the start of the coronavirus pandemic and signal that a fledging economic recovery is likely to be uneven. See full story.
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
Inovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars in funding to scale up manufacturing capacity. See full story.
Gold and silver penny stocks could be the next Robinhood trader…